Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Disclosure of terms and conditions of share-based payment arrangement [line items]

Schedule of expense recognized

	Year ended December 31
	2022		2021		2020
Cost of revenues		184		153		115
Research and development		406		333		179
Selling and marketing		42		-		3
General and administrative		1,314		1,187		1,025
Total share-based compensation		1,946		1,673		1,322

Schedule of share options activity

	2022					2021*					2020*
	Number of options			Weighted Average Exercise price		Number of options			Weighted Average Exercise price		Number of options			Weighted Average Exercise price
Outstanding Options at beginning of year		537,288			44.45		513,973			45.85		333,490			64.26
Options Granted		320,775			14.25		53,970			37.52		182,054			10.01
Options Exercised		(807	)		12.23		(536	)		20.16		-			-
Options Forfeited and/or expired		(92,489	)		55.58		(30,119	)		56.91		(1,571	)		50.33
Outstanding options and at end of year		764,767			30.44		537,288			44.45		513,973			45.85
Option's Exercisable at end of year		373,681			46.18		333,618			58.38		278,859			69.86

*Restated o reflect 1:7 reverse ratio of shares (See note 18b)

Schedule of information about share options outstanding

	Options outstanding as of December 31, 2022
Range of exercise prices ($ )	Number of options		Weighted Average Remaining contractual life		Weighted average exercise price
12.25-14.42		470,693		7.84		13.60
26.88-37.52		145,354		6.43		35.95
42.14-67.06		68,662		2.85		63.94
90.23-96.32		80,058		0.91		90.65
Total		764,767		6.40		30.44

	Options outstanding as of December31, 2021*
Range of exercise prices ($)	Number of options		Weighted Average Remaining contractual life		Weighted average exercise price
12.25-37.52		329,638		6.19		23.03
42.14-67.06		91,750		3.68		63.07
90.23-96.32		115,900		1.92		90.51
Total		537,288		4.84		44.45

Schedule of RSU's outstanding

	RSU's 2022			RSU's 2021*			RSU's 2020*
Outstanding at beginning of year		14,581			10,655			15,506
Granted		39,286			8,992			-
Forfeited		(27	)		(215	)		-
Vested		(11,827	)		(4,851	)		(4,851	)
Outstanding at the end of the period		42,013			14,581			10,655

*Restated o reflect 1:7 reverse ratio of shares (See note 18b)

Schedule of fair value assumptions

 

	December 31
	2022		2021		2020
Dividend yield (%)		0		0		0
Expected volatility of the share prices (%)		59-77		55-78		51-71
Risk-free interest rate (%)		2.1-5.2		0.1-1.5		0.2-0.9
Early exercise factor (%)		100-150		100-150		100-150
Weighted average share prices (Dollar)		7.98		20.16		17.01